Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities.

Cite

CITATION STYLE

APA

Davis, A., & Mendez, D. D. (2022). Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning. Health Equity, 6(1), 55–58. https://doi.org/10.1089/heq.2021.0122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free